NEW

Earlier this year, the United States Food and Drug Administration (FDA) published a Federal Register notice requesting comments on…

Humana is suing the United States Department of Health and Human Services (HHS) over the plan to audit Medicare Advantage…

The United States House of Representatives Energy and Commerce Committee Subcommittee on Health recently held a hearing,…

Artificial intelligence – or AI – is a popular buzzword right now. But what does it mean for the health care industry? While it…

Recently, the United States Federal Trade Commission (FTC) announced a settlement with Surescripts over the company’s alleged use…

In the ever-evolving field of oncology, staying up to date with the latest advancements and best practices is crucial for…

Recently, the Centers for Medicare and Medicaid Services (CMS) announced a third set of Medicare Part B prescription drugs that…

Patent protections for new drugs have ignited an unparalleled surge of innovation, significantly benefiting patients, and should…

A bipartisan group of United States Representatives introduced the Medicaid VBPs for Patients (MVP) Act of 2023 to further enhance…

Recently, Epic published research that found that telehealth patients are often less likely to attend follow-up visits, when…